← All trials
NCT01203358
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 1991
- Primary completion
- Jan 1, 1992
- Completion date
- Jan 1, 1992
- First posted
- —
- Last posted
- —
- Enrollment
- 617
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Child Health and Human Development (NICHD)Lead sponsor
- Case Western Reserve UniversityOverall official - principal investigator
- University of TennesseeOverall official - principal investigator
- Wayne State UniversityOverall official - principal investigator
- University of MiamiOverall official - principal investigator
- Indiana UniversityOverall official - principal investigator
- Emory UniversityOverall official - principal investigator
- Stanford UniversityOverall official - principal investigator
- University of New MexicoOverall official - principal investigator
- University of VermontStudy director
- George Washington UniversityOverall official - principal investigator
- University of CincinnatiOverall official - principal investigator
- The University of Texas, DallasOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.